Autori: Zupancic-Salek Silva
| Naslov | Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial (Article) |
| Autori | Lentz Steven R Janic Dragana M Kavakli Kaan Miljic Predrag S Oldenburg Johannes Ozelo Margareth Castro Santagostino Elena Suzuki Takashi Zupancic-Salek Silva Korsholm Lars Matytsina Irina Tiede Andreas |
| Info | HAEMOPHILIA, (2018), vol. 24 br. 6, str. E391-E394 |
| Projekat | Novo Nordisk A/S |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Beyond patient benefit: clinical development in hemophilia (Review) |
| Autori | Auerswald Guenter Zupancic-Salek Silva Benson Gary Elezovic Ivo V Lambert Thierry Morfini Massimo Pasi John Remor Eduardo Santagostino Elena Salaj Peter Ljung Rolf |
| Info | HEMATOLOGY, (2012), vol. 17 br. 1, str. 1-8 |
| Projekat | Novo Nordisk Region Europe A/S |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice (Review) |
| Autori | Benson Gary Auerswald Guenter Elezovic Ivo V Lambert Thierry Ljung Rolf Morfini Massimo Remor Eduardo Zupancic-Salek Silva |
| Info | EUROPEAN JOURNAL OF HAEMATOLOGY, (2012), vol. 88 br. 5, str. 371-379 |
| Projekat | Bayer; Baxter; Novo Nordisk; Octapharma; CSL Behring; Pfizer; Novo Nordisk Region Europe A/S |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
